Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals
This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases.
CPRX CEO Highlights Strong Q1 & Growth Prospects Despite Market Challenges
Catalyst Pharmaceuticals (CPRX) CEO Rich Daly on the company's strong 1Q, growth drivers, and its cash-rich position in a challenging market. Daly discusses the company's pipeline, including plans to expand its product for Lambert-Eaton Myasthenic Syndrome (LEMS) into the oncology space and potenti…
Navigating Funding Freezes and AI Frontiers
Lori Ellis, head of insights at BioSpace, discusses some of the recent events and topics that are buzzing around BIO and DIA in 2025 with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors. They address funding, the par…
Episode 613: Episode 25-07 Climate Change and Our Brain
On this week’s Tech Nation, Moira speaks with Environmental journalist and Rhodes scholar Clayton Page Aldern about his book, “The Weight of Nature … How a Changing Climate Changes Our Brains”. Then, Rich Daly, CEO of Catalyst Pharmaceuticals, about managing multiple medications and making sure lif…
Episode 613: Episode 25-07 Climate Change and Our Brain
On this week’s Tech Nation, Moira speaks with Environmental journalist and Rhodes scholar Clayton Page Aldern about his book, “The Weight of Nature … How a Changing Climate Changes Our Brains”. Then, Rich Daly, CEO of Catalyst Pharmaceuticals, about managing multiple medications and making sure lif…
BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals
We love to hear from our listeners. Send us a message.
On this week's episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharmaceuticals, a member of Life Science Leader's editorial advisory board and Miami-based location host for our …
Biopharma CEOs assess the road ahead in 2026
After a turbulent 2025, the biopharma industry is heading into the new year with major questions still unresolved.
A tough biotech investing environment, aggressive direct-to-consumer drug marketing and sweeping U.S. policy changes reshaped the landscape last year. Many of those pressures are expe…
Episode 125 - Rich Daly - CEO of Catalyst Pharma
Today I’m joined by Rich Daly, CEO of Catalyst Pharmaceuticals — one of the standout rare-disease success stories in the industry and recently named one of America’s most successful small-cap companies by Forbes.
Rich has spent more than 25 years leading organisations across biotech and pharma — i…
We Got Your 6@6 with THE PEOPLE'S PATRIOT PROJECT
Barnside Brotherhood: Jason Sedotal & Nick Crouch
This episode introduced us to two incredible veterans whose mission is to help fellow service members heal through connection, purpose, and the unique bond between humans and horses.
Jason's military journey took him straight to Iraq, followed by…
Special Episode: UM Hurricanes
This special episode of the BiotechMiami Salon brings you video of the panel discussion on the topic "Building Championship Teams in Sports and Biotech" from a September 2026 event at the Miami Hurricanes Football Indoor Practice Facility hosted by BiotechMiami community member Raquel Cabo on behal…
SEARCH ENGINE NG PODCAST
Maaari mong gamitin ang aming website upang maghanap ng mga3,825,391na mga podcast at195,885,949na mga episode ayon sa mga tao, lugar, o paksa.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
I-EDIT
Salamat sa pagtulong na mapanatiling naka-update ang database ng podcast.
